Kidney Medicine (Sep 2020)

Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor—A Report of 3 Cases

  • Sandra M. Herrmann,
  • Mariam P. Alexander,
  • Michael F. Romero,
  • Ladan Zand

Journal volume & issue
Vol. 2, no. 5
pp. 657 – 662

Abstract

Read online

The main cause of acute kidney injury in patients receiving immune checkpoint inhibitors (ICIs) is acute interstitial nephritis. However, as their use continues to increase, other kidney manifestations are being described. We report 3 cases of patients treated with ICIs who developed predominantly electrolyte disorders secondary to renal tubular acidosis as an immune-related adverse event and discuss the potential mechanism. Nongap acidosis in combination with hypokalemia should raise suspicion for distal renal tubular acidosis in patients treated with ICIs.

Keywords